Osteoporosis Dx Firm Osteolabs Inks Commercialization Deals in Germany, Turkey

Jan 20, 2020

|

NEW YORK – German startup Osteolabs announced on Monday its first commercialization agreements covering Germany and Turkey.

In Germany, Osteolabs has signed a deal with Eurofins LifeCodexx to commercialize Osteolabs' diagnostic test for the early detection of osteoporosis. The company has reached a similar deal in Turkey with BioGen Medical.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Osteoporosis Dx Firm Osteolabs Inks Commercialization Deals in Germany, Turkey

To read the full story....

Breaking News

Somalogic Closes $121M Series A Funding

FDA Issues EUAs for Gravity Diagnostics Coronavirus Test, Sample Self-Collection Kit from RapidRona

Kantaro Biosciences Gets FDA Emergency Use Authorization for Coronavirus Antibody Test

In Brief This Week: Quest Diagnostics, Fluidigm, BD, and More

Tempus Gets CE Mark for xT Tumor Sequencing Assay

BTIG Downgrades Fulgent Genetics from Buy to Neutral

What's Popular?

FDA Issues EUAs for Gravity Diagnostics Coronavirus Test, Sample Self-Collection Kit from RapidRona

BTIG Downgrades Fulgent Genetics from Buy to Neutral

Quest Diagnostics Enters Lab Services Agreement With Montefiore Nyack, Goshen Hospital

Kantaro Biosciences Gets FDA Emergency Use Authorization for Coronavirus Antibody Test

Abviris Developing Blood-Based Serology Test For HPV-Related Cancers

Sponsorships